5.05
price down icon7.52%   -0.40
after-market Dopo l'orario di chiusura: 5.05
loading

Immuneering Corp Azioni (IMRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
10.58%
13.75
15.38 - 15.48 18.56
Operating Income/Loss
10.58%
-13.75
-15.38 - -15.48 -18.56
Income/Loss From Continuing Operations Before Tax
22.62%
-11.58
-14.96 -14.43 -15.05 -18.05
Income/Loss From Continuing Operations After Tax
22.62%
-11.58
-14.96 -14.43 -15.05 -18.05
Net Income/Loss
22.62%
-11.58
-14.96 -14.43 -15.05 -18.05
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
82.52%
6.9348
39.67 - 35.53 0.3589
Diluted Average Shares
82.52%
6.9348
39.67 - 35.53 0.3589
Basic Earnings Per Share
81.58%
-0.07
-0.38 - -0.42 -0.59
Diluted Earnings Per Share
81.58%
-0.07
-0.38 - -0.42 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.87
price up icon 0.18%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$139.44
price down icon 0.28%
biotechnology ONC
$288.30
price up icon 0.99%
Capitalizzazione:     |  Volume (24 ore):